These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21334847)

  • 1. Therapy of polymyositis and dermatomyositis.
    Marie I
    Presse Med; 2011 Apr; 40(4 Pt 2):e257-70. PubMed ID: 21334847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of polymyositis and dermatomyositis.
    Marie I; Mouthon L
    Autoimmun Rev; 2011 Nov; 11(1):6-13. PubMed ID: 21740984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.
    Unger L; Kampf S; Lüthke K; Aringer M
    Rheumatology (Oxford); 2014 Sep; 53(9):1630-8. PubMed ID: 24706995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E
    Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab as therapy for refractory polymyositis and dermatomyositis.
    Noss EH; Hausner-Sypek DL; Weinblatt ME
    J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients.
    Efthimiou P; Schwartzman S; Kagen LJ
    Ann Rheum Dis; 2006 Sep; 65(9):1233-6. PubMed ID: 16476710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of polymyositis and dermatomyositis.
    Kaye SA; Isenberg DA
    Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L51. From immunosuppression to selective treatments: the benefit-risk ratio.
    Guillevin L
    Presse Med; 2013 Apr; 42(4 Pt 2):641-3. PubMed ID: 23453210
    [No Abstract]   [Full Text] [Related]  

  • 10. Biologics in polymyositis and dermatomyositis-associated interstitial lung disease.
    Sun Y; He Y; Liu Y; Shi G
    Curr Pharm Biotechnol; 2014; 15(6):521-4. PubMed ID: 25213360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory polymyositis and dermatomyositis.
    Ytterberg SR
    Curr Rheumatol Rep; 2006 Jun; 8(3):167-73. PubMed ID: 16901073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.
    Schiopu E; Phillips K; MacDonald PM; Crofford LJ; Somers EC
    Arthritis Res Ther; 2012 Jan; 14(1):R22. PubMed ID: 22284862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of polymyositis and dermatomyositis.
    Findlay AR; Goyal NA; Mozaffar T
    Muscle Nerve; 2015 May; 51(5):638-56. PubMed ID: 25641317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L44. Management of relapses in vasculitis.
    Mouthon L
    Presse Med; 2013 Apr; 42(4 Pt 2):619-22. PubMed ID: 23477710
    [No Abstract]   [Full Text] [Related]  

  • 17. Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis.
    Yokoyama Y; Furuta S; Ikeda K; Hirose K; Nakajima H
    Mod Rheumatol; 2015; 25(6):888-92. PubMed ID: 25775144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory myopathies in Nigerians: case series and literature review.
    Adelowo OO; Edomwonyi U; Olaosebikan H
    Afr J Med Med Sci; 2013 Jun; 42(2):143-9. PubMed ID: 24377199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2004 Jun; 25 Suppl 1():S22-5. PubMed ID: 15165688
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.